Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R1124 [Leu5]-Enkephalin, amide 554.6 C28H38N6O6
R1125 [Met5]-Enkephalin, amide 572.7 C27H36N6O6S
R1126 [Nle11]-Substance P 1329.59 C₆₄H₁₀₀N₁₈O₁₃
R1127 [pThr3]-CDK5 Substrate 1218.43 C₅₃H₁₀₀N₁₅O₁₅P
R1128 [pTyr1146][pTyr1150][pTyr1151]Insulin Receptor 1142-1153 1862.67 C₇₂H₁₁₀N₁₉O₃₃P₃
R1129 [pTyr5] EGFR 988-993 804.69 C₃₁H₄₅N₆O₁₇P
R1131 [Sar1, Ile8]-Angiotensin II 968.2 C46H73N13O10
R1132 [Sar1, Ile8]-Angiotensin II TFA 1082.18 C₄₈H₇₄F₃N₁₃O₁₂
R1133 [Sar9,Met(O2)11]-Substance P 1393.7 C64H100N18O15S
R1134 [Sar9] Substance P 1361.7 C64H100N18O13S
R1135 [SER140]-PLP(139-151) 1521.7 C72H104N20O17
R1136 123C4 807.34 C₄₃H₄₇ClN₈O₆
R1137 2: PN: US20040072744 SEQID: 2 claimed protein 1070.13 C₄₃H₆₇N₁₃O₁₇S
R1138 26Rfa, Hypothalamic Peptide, human 2832.13 C₁₂₇H₁₉₅N₃₇O₃₇
R1140 3X FLAG peptide TFA 2975.84 C₁₂₂H₁₇₀F₃N₃₁O₅₁S
R1141 5-Tamra-DRVYIHP 1313.46 C₆₆H₈₄N₁₄O₁₅
R1142 Abl Cytosolic Substrate 1336.58 C₆₄H₁₀₁N₁₅O₁₆
R1143 Abz-FR-K(Dnp)-P-OH 831.9 C39H49N11O10
R1145 Ac2-26 TFA 3203.45 C₁₄₃H₂₁₁F₃N₃₂O₄₆S
R1146 Ac-DEVD-AFC 729.6 C30H34F3N5O13